Biontech Se Adr (BNTX)

Oct 01, 2026

BioNTech CEO sells 39,000 shares. BioNTech stock has a USD 126.00 average target - AD HOC NEWS

Oct 01, 2026

Oct 01, 2026

BioNTech SE (BNTX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Oct 01, 2026

Sep 30, 2026

Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now? - TradingView

Sep 30, 2026

Sep 30, 2026

Head and Neck Squamous Cell Carcinoma (HNSCC)Market Insights, Epidemiology, and Market Forecast - GlobeNewswire Inc.

Sep 30, 2026

Sep 28, 2026

BioNTech SE (CEUX:22UAd)Valuation Measures & Financial Statistics - GuruFocus

Sep 28, 2026

Sep 28, 2026

BioNTech SE (BNTX) stock price, news, quote and history - Yahoo Finance Australia

Sep 28, 2026

Sep 27, 2026

BioNTech Balances Breakthrough Cancer Data Against a Messy Founder Split () - aktiencheck.de

Sep 27, 2026

Sep 25, 2026

BNTX Stock Quote Price and Forecast - CNN

Sep 25, 2026

Sep 25, 2026

Form 4 BioNTech SE For: 25 September - Investing.com India

Sep 25, 2026

Sep 24, 2026

BioNTech (BNTX) 10K Form and Latest SEC Filings 2026 - MarketBeat

Sep 24, 2026

Sep 23, 2026

BNTX Stock Price and Chart — NASDAQ:BNTX - tradingview.com

Sep 23, 2026

Sep 23, 2026

BioNTech SE (22UA.F) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 23, 2026

Sep 22, 2026

BioNTech Steps Deeper Into Lung Cancer With New Dareon-Rosetta35 Trial - TipRanks

Sep 22, 2026

Sep 21, 2026

eBay Upgraded, Airbnb Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Sep 21, 2026

Sep 17, 2026

BioNTech CEO Sahin Ugur Sells 49,000 Shares, Retains 553,209 Shares Post-Transaction - Kalkine Media

Sep 17, 2026

Sep 14, 2026

"MarketWatch" Features Halberd Corporation With Prominent Pharmaceutical Companies on New Treatments for COVID-19 - ACCESS Newswire

Sep 14, 2026

Sep 14, 2026

BioNTech's lung cancer drug outperforms chemo in clinical study - mugglehead.com

Sep 14, 2026

Sep 12, 2026

BioNTech's Oncology Credibility Test Comes Down to Four Days in Seoul () - aktiencheck.de

Sep 12, 2026

Sep 09, 2026

Pfizer Stock Rises Almost 9% in 3 Months: Time to Buy, Hold or Exit? - TradingView

Sep 09, 2026

Sep 09, 2026

BioNTech's Downsizing Signal: Factory Divestitures and a Trimmed Forecast Frame the Pipeline Debate - aktiencheck.de

Sep 09, 2026

Sep 08, 2026

Advanced Micro Devices Upgraded, Eli Lilly Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Sep 08, 2026

Sep 08, 2026

BioNTech CEO Ugur Sahin Executes Sale of 76,500 Shares Under Rule 10b5-1 Plan - Kalkine Media

Sep 08, 2026

Sep 08, 2026

Why Pfizer Stock Was so Healthy in August - The Motley Fool

Sep 08, 2026

Sep 08, 2026

This Best Buy Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday - Benzinga

Sep 08, 2026

Sep 08, 2026

Robinhood To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

Sep 08, 2026

Sep 08, 2026

Why is BioNTech stock sliding today? - investing.com

Sep 08, 2026

Sep 06, 2026

BioNTech's Promising Oncology Pipeline Is Now in Late-Stage Development - Morningstar

Sep 06, 2026

Sep 06, 2026

BioNTech's Balancing Act: A COVID Lifeline Arrives Just as Oncology Investors Need a Reason to Stay - aktiencheck.de

Sep 06, 2026

Sep 04, 2026

PTC Therapeutics (PTCT) Moves 7.2% Higher: Will This Strength Last? - easternprogress.com

Sep 04, 2026

Sep 04, 2026

BioNTech's High-Stakes Seoul Debut: A Cash-Rich Pivot Meets Its First Real Test () - aktiencheck.de

Sep 04, 2026

Sep 04, 2026

BioNTech's September Test: Can Oncology Data Outweigh a Shrinking COVID Franchise? () - aktiencheck.de

Sep 04, 2026

Sep 03, 2026

BioNTech SEADR (BNTX) Fundamental & Financial Data - Stocktwits

Sep 03, 2026